Join PEM, Stratagem IPM Ltd and Laser 2000 for an exclusive breakfast seminar designed for innovative founders and ambitious post docs.
Cambridge is one of the world’s leading scientific ecosystems, with extraordinary innovations emerging frequently from research labs, spin-outs and engineering teams. But there is often a gap between a breakthrough idea and a business that investors are ready to back. Even strong innovation can struggle without the right structure, planning and use of available incentives to support growth.
At PEM, we work with innovation-led companies at every stage of growth, and see how critical it is to align financial strategy, tax planning and commercial goals from an early stage. That’s why we are co-hosting a free seminar in Cambridge specifically for innovators.
From Innovation to Impact – Enabling the next generation of science-driven companies
Organised in collaboration with Laser 2000 and Stratagem IPM, this session brings together expertise across technology, intellectual property and financial strategy to explore how ideas move from research into successful, investment-ready businesses.
Date: Tuesday 2 June
Time: 8:00am – 11:30am
Location: Ray Dolby Centre, Cambridge
You will gain practical insight into how to position your company for investment, and the opportunity to network with peers and speak face to face with experts across technology, IP and finance. We hope you are able to join us.
This is a free event, with limited spaces available. Secure your place now and learn how to turn innovation into a commercially viable, investment ready business.
Meet the speakers
David Gillett – CEO, Laser 2000
David Gillett leads Laser 2000 UK. Since leading a management buyout in 2021, he has driven international growth across the photonics sector and specialises in scaling technology-driven businesses and bringing advanced technologies into global markets.
Sian Billson – Head of Life Sciences, Stratagem IPM
Sian Bilson leads Stratagem’s Chemistry and Life Sciences patents team and brings more than 25 years of pharmaceutical IP experience. Formerly at GSK, she managed global patent portfolios and now advises innovation-led companies on IP strategies to support business growth and investment.
Jan Fachot is a Partner at PEM, advising businesses and their owners on a wide range of corporate and personal tax matters. As Head of PEM’s Business Tax team, he supports companies from early-stage start-ups to global organisations across multiple sectors.
